Total pancreatectomy for pancreatic adenocarcinoma: Evaluation of morbidity and long-term Survival

Annals of Surgery

Volumn 250, Issue 2, 2009, Pages 282-287

  Reddy, Sushanth ^a   Wolfgang, Christopher L ^a   Cameron, John L ^a   Eckhauser, Frederic ^a   Choti, Michael A ^a   Schulick, Richard D ^a   Edil, Barish H ^a   Pawlik, Timothy M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CANCER INVASION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GLYCEMIC CONTROL; HEART DISEASE; HISTOPATHOLOGY; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LUNG DISEASE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIPLE ORGAN FAILURE; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; STOMACH EMPTYING; SURVIVAL; TUMOR VOLUME; ADENOCARCINOMA; COHORT ANALYSIS; COMPARATIVE STUDY; MIDDLE AGED; MORTALITY; PANCREAS TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 68949083589     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181ae9f93     Document Type: Article

References (38)

1. Sohn TA, Campbell KA, Pitt HA, et al. Quality of life and long-term survival after surgery for chronic pancreatitis. J Gastrointest Surg. 2000;4:355-364; discussion 364-365.
2. Pliam MB, ReMine WH. Further evaluation of total pancreatectomy. Arch Surg. 1975;110:506-512.
3. Grace PA, Pitt HA, Tompkins RK, et al. Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg. 1986;151:141-149.
4. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancre-aticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg. 1997;226:248-257; discussion 257-260.
5. Dresler CM, Fortner JG, McDermott K, et al. Metabolic consequences of (regional) total pancreatectomy. Ann Surg. 1991;214:131-140.
6. Pezzilli R. Diabetic control after total pancreatectomy. Dig Liver Dis. 2006; 38:420-422.
7. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gas-trointest Surg. 2000;4:567-579.
8. Reddy SK, Tyler DS, Pappas TN, et al. Extended resection for pancreatic adenocarcinoma. Oncologist. 2007;12:654-663.
9. Schmidt CM, Glant J, Winter JM, et al. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery. 2007;142:572-578; discussion 578-580.
10. Nathan H, Wolfgang CL, Edil BH, et al. Perioperative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol. 2009;99:87-92.
11. Muller MW, Friess H, Kleeff J, et al. Is there still a role for total pancreatec-tomy? Ann Surg. 2007;246:966-974; discussion 974-975.
12. Karpoff HM, Klimstra DS, Brennan MF, et al. Results of total pancreatec-tomy for adenocarcinoma of the pancreas. Arch Surg. 2001;136:44-47; discussion 48.
13. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
14. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
15. ReMine WH, Priestley JT, Judd ES, et al. Total pancreatectomy. Ann Surg. 1970;172:595-604.
16. Gordon TA, Burleyson GP, Tielsch JM, et al. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg. 1995;221:43-49.
17. Lieberman MD, Kilburn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg. 1995;222:638-645.
18. Nathan H, Cameron JL, Choti MA, et al. The Volume-outcome effect in hepato-pancreato-biliary surgery: hospital versus surgeon contributions and specificity of the relationship. J Am Coll Surg. 2009;208:528-538.
19. Kahl S, Malfertheiner P. Exocrine and endocrine pancreatic insuffici-ency after pancreatic surgery. Best Pract Res Clin Gastroenterol. 2004;18: 947-955.
20. Slezak LA, Andersen DK. Pancreatic resection: effects on glucose metabolism. World J Surg. 2001;25:452-460.
21. Sarr MG, Behrns KE, van Heerden JA. Total pancreatectomy: an objective analysis of its use in pancreatic cancer. Hepatogastroenterology. 1993;40: 418-421.
22. Govindarajan A, Tan JC, Baxter NN, et al. Variations in surgical treatment and outcomes of patients with pancreatic cancer: a population-based study. Ann Surg Oncol. 2008;15:175-185.
23. McPhee JT, Hill JS, Whalen GF, et al. Perioperative mortality for pancrea-tectomy: a national perspective. Ann Surg. 2007;246:246-253.
24. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008;15:415-423.
25. Scalea TM, Bochicchio GV, Bochicchio KM, et al. Tight glycemic control in critically injured trauma patients. Ann Surg. 2007;246:605-610; discussion 610-1602
26. Tuggle DW, Kuhn MA, Jones SK, et al. Hyperglycemia and infections in pediatric trauma patients. Am Surg. 2008;74:195-198.
27. Bochicchio GV, Joshi M, Bochicchio KM, et al. Early hyperglycemic control is important in critically injured trauma patients. J Trauma. 2007;63:1353-1358; discussion 1358-1359.
28. Kiviluoto T, Schroder T, Karonen SL, et al. Glycemic control and serum lipoproteins after total pancreatectomy. Ann Clin Res. 1985;17:110-115.
29. Sauvanet A. Functional results of pancreatic surgery [in French] Rev Prat. 2002;52:1572-1575.
30. Duron F, Duron JJ. Pancreatectomy and diabetes -in French-. Ann Chir. 1999;53:406-411.
31. Jethwa P, Sodergren M, Lala A, et al. Diabetic control after total pancreatec-tomy. Dig Liver Dis. 2006;38:415-419.
32. Billings BJ, Christein JD, Harmsen WS, et al. Quality-of-life after total pancreatectomy: is it really that bad on long-term follow-up? J Gastrointest Surg. 2005;9:1059-1066; discussion 1066-1067.
33. Sugiyama M, Atomi Y. Pylorus-preserving total pancreatectomy for pancreatic cancer. World J Surg. 2000;24:66-70; discussion 70-71.
34. Yamaguchi K, Konomi H, Kobayashi K, et al. Total pancreatectomy for intraductal papillary-mucinous tumor of the pancreas: reappraisal of total pancreatectomy. Hepatogastroenterology. 2005;52:1585-1590.
35. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocar-cinoma. Ann Surg. 2007;246:52-60.
36. Asiyanbola B, Gleisner A, Herman JM, et al. Determining pattern of recurrence following pancreaticoduodenectomy and adjuvant 5-fluroura-cil-based chemoradiation therapy: effect of number of metastatic lymph nodes and lymph node ratio. J Gastrointest Surg. 2009;13:752-759.
37. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141:610-618.
38. Gleisner AL, Assumpcao L, Cameron JL, et al. Is Resection of Periampullary or Pancreatic Adenocarcinoma with Synchronous Hepatic Metastasis Justi-fied. Cancer. 2007;110:2484-2492.